1.65

0.61% 0.01

Lisata Therapeutics Inc (LSTA)

Overview News Price History Financials Discussions Forecast Stock Split

Lisata Therapeutics Inc stock is traded at $1.65, with a volume of 32,392. It is up +0.61% in the last 24 hours and up +44.74% over the past month. Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Previous Close:

$1.64

Open:

$1.58

24h Volume:

32,392

Relative Volume:

0.15

Market Cap:

$14.87M

Revenue:

$170.00K

Net Income/Loss:

$-16.35M

P/E Ratio:

-0.8869

EPS:

-1.8605

Net Cash Flow:

$-13.66M

1W Performance:

-2.37%

1M Performance:

+44.74%

6M Performance:

-61.72%

1Y Performance:

-21.80%

1-Day Range:

$1.5637

$1.70

1-Week Range:

$1.234

$1.71

52-Week Range:

$0.9875

$5.07

Lisata Therapeutics Inc Stock (LSTA) Company Profile

Name

Lisata Therapeutics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

908-229-2590

Address

110 ALLEN ROAD, BASKING RIDGE

Employee

Twitter

Next Earnings Date

2026-08-20

Latest SEC Filings

LSTA's Discussions on Twitter

Compare LSTA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LSTA Lisata Therapeutics Inc	1.65	10.09M	170.00K	-16.35M	-13.66M	-1.8605
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Lisata Therapeutics Inc Stock (LSTA) Latest News

Aug 21, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Aug 21, 2026

Aug 19, 2026

Lisata Therapeutics Inc. (NASDAQ: LSTA) Share Price, LSTA Stock News, LSTA Share Price & Updates - Kalkine

Aug 19, 2026

Aug 18, 2026

Lisata (LSTA) Trading Levels Update: Climbs 6.48% to $1.15 in the Latest Session; Technical Focus: $1.09 and $1.21 Define the Nearby Reference LevelsHull Moving Average - Vinanet

Aug 18, 2026

Aug 14, 2026

Enterprise value to EBITDA forward of Lisata Therapeutics, Inc. – FWB:8NE - TradingView

Aug 14, 2026

Aug 13, 2026

Lisata Therapeutics (LSTA) Drops 4.24% to $1.13, Approaching Critical SupportBlue Chip Entry Points - Vinanet

Aug 13, 2026

Enterprise value to EBITDA forward of Lisata Therapeutics, Inc. – SWB:8NE - TradingView

Aug 13, 2026

Aug 08, 2026

Enterprise value to EBIT forward of Lisata Therapeutics, Inc. – NASDAQ:LSTA - TradingView

Aug 08, 2026

Lisata Therapeutics (8NE) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks

Aug 08, 2026

Aug 07, 2026

Lisata Therapeutics (LSTA) Slips 0.93% as Shares Hover Near Key Support at $1.02Money Flow - vinanet.vn

Aug 07, 2026

Aug 06, 2026

LISATA THERAPEUTICS, INC. 2026: Revenue $0 EPS ($0.32) — 10-Q Summary - TradingView

Aug 06, 2026

Aug 05, 2026

Lisata Therapeutics Announces Major Workforce Reduction and Retrenchment - The Globe and Mail

Aug 05, 2026

Aug 04, 2026

Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce By Investing.com - Investing.com India

Aug 04, 2026

Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce - Investing.com

Aug 04, 2026

Lisata Therapeutics, Inc. Continues to Evaluate Strategic Alternatives to Enhance Stockholder Value - marketscreener.com

Aug 04, 2026

Lisata Therapeutics (LSTA) Pursues Legal Action After Merger Ter - GuruFocus

Aug 04, 2026